8 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... Hypertension (PAH ... #Management #Algorithm ... #treatment #pharmacology
Pulmonary Hypertension Algorithm - Matthew Watto, MD
#Diagnosis #Management #Pulmonary #Hypertension #PAH #Workup #Evaluation #Algorithm #Differential #Curbsiders
Pulmonary Hypertension ... Algorithm - Matthew ... Watto, MD #Diagnosis ... #Management #Pulmonary ... #Hypertension #PAH
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Hypertension (PAH ... ) Management Algorithm ... #Hypertension #PAH ... #Management #Algorithm ... #treatment #pharmacology
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Pericardial tamponade, Pulmonary ... vasoactive drug pharmacology ... #inopressors #diagnosis ... #management #comparison ... #table
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
disequilibrium syndrome • Diagnosis ... irrigation • Management ... Torsemide) • Acute pulmonary ... #Pharmacology # ... Medications #Table
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
simply a clinical diagnosis ... with presence of pulmonary ... #algorithm #management ... cardiology #treatment #table ... icu #clinical #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... days before Pulmonary ... medical and surgical management ... stratification #diagnosis
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... amyloidosis, PAH ... lubricants • Pharmacologic ... #Management